Ferraz Lynce is currently a recognised name in the pharmaceutical market in Portugal, standing out for the principles of Ethics, Rigour and Quality that guide all its activities. Becoming part of the IBERFAR Group – which brings more than a century of experience in the pharmaceutical field – further reinforces this identity and our commitment to excellence.

Fully aware that we operate in a highly sensitive sector, where public health and the well-being of the population outweigh commercial interests, we approach every project with a strong sense of responsibility and respect, especially in emerging therapeutic areas with major social relevance, such as medicinal cannabis.

The mutual trust built with our partners is reflected in the lasting nature and regular renewal of our contracts, resulting in tangible results and the creation of new collaborative opportunities. This shared vision is essential for the sustainable and ethical development of this new business area.

The Ferraz Lynce Business Development Department plays a central role in managing existing partnerships and in the ongoing identification and assessment of new opportunities, working closely with the various business units and functional departments of the IBERFAR Group.

When we identify an opportunity that aligns with the Group’s portfolio, technical capabilities or strategic objectives, we commit the resources needed to ensure the success of each project.

We promote innovative projects – from research and development through to production, marketing and market access.

By adopting this vision, Ferraz Lynce stands as a solid and reliable partner in the expansion of responsible and sustainable businesses.

By nature and conviction, our attitude towards every partner is guided by the values of transparency, integrity, reliability, continuous communication and a long-term perspective.